Empagliflozin 25 mg Tablet is an oral antidiabetic medication used primarily for the treatment of Type 2 diabetes mellitus in adults and children aged 10 years and older. It belongs to the class of drugs known as sodium-glucose co-transporter-2 (SGLT-2) inhibitors. Empagliflozin helps control high blood sugar levels by reducing the reabsorption of glucose in the kidneys, thereby increasing glucose excretion through urine. This mechanism not only lowers blood sugar but also reduces the risk of serious complications associated with diabetes, such as kidney damage (diabetic nephropathy), blindness (diabetic retinopathy), nerve damage (diabetic neuropathy), and cardiovascular events like heart attack or stroke. Additionally, it may provide benefits for heart failure and chronic kidney disease in certain patients.
Uses:
- Primary Use: Treatment of Type 2 diabetes mellitus when diet and exercise alone are insufficient to control blood sugar levels.
- Additional Uses:
- Reduces the risk of cardiovascular death in adults with Type 2 diabetes and established heart disease.
- Lowers the risk of hospitalization or death due to heart failure in adults with heart failure.
- May be used to manage chronic kidney disease in certain cases.
- It is often prescribed alone or in combination with other diabetes medications (e.g., metformin, insulin, sulfonylureas) as part of a comprehensive treatment plan that includes diet, exercise, and weight management.
-
Composition:
- Active Ingredient: Empagliflozin (25 mg per tablet).
- Inactive Ingredients: Vary by manufacturer but may include lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, and film-coating agents. Check the product label for specific excipients.
-
Dosage and Administration:
- Recommended Dose: Typically one 25 mg tablet taken once daily, with or without food, preferably at the same time each day. The dose may be adjusted by a doctor based on the patient’s condition, kidney function, and response to treatment (e.g., starting at 10 mg and increasing to 25 mg if needed).
- Administration: Swallow the tablet whole with water. Do not crush, chew, or break it.
- Missed Dose: Take the missed dose as soon as remembered unless it’s close to the next dose. Do not double the dose to make up for a missed one.
- Important: Dosage should be determined by a healthcare provider. Do not stop or adjust the dose without consulting a doctor, as this may lead to uncontrolled blood sugar levels.
-
How It Works:
Empagliflozin inhibits the SGLT-2 enzyme in the proximal tubules of the kidneys, reducing glucose reabsorption and promoting its excretion in urine. This lowers blood glucose levels independently of insulin production, making it effective for Type 2 diabetes management. It also reduces sodium retention and fluid overload, which benefits heart and kidney health. The effects on blood sugar may be noticeable within 1–2 weeks of starting treatment.
Side Effects:
- Common Side Effects:
- Urinary tract infections (e.g., pain or burning during urination, frequent urination).
- Genital mycotic infections (e.g., vaginal yeast infections in women, balanitis in men).
- Increased urination or thirst.
- Dehydration (may cause dizziness or weakness).
- Mild skin rash or itching.
- Serious Side Effects (seek medical attention if these occur):
- Signs of diabetic ketoacidosis (e.g., nausea, vomiting, stomach pain, tiredness, difficulty breathing).
- Severe allergic reactions (e.g., rash, swelling of face/lips/tongue, breathing difficulty).
- Low blood sugar (hypoglycemia), especially if combined with insulin or sulfonylureas (symptoms include shakiness, sweating, confusion).
- Kidney problems (e.g., reduced urine output, swelling in legs).
- Fournier’s gangrene (a rare but serious genital infection).
- Note: Side effects are generally mild and may resolve as the body adjusts. Consult a doctor if they persist or worsen???????.
-
Precautions and Warnings:
- Allergies: Do not take if allergic to empagliflozin or any tablet ingredients.
- Contraindications:
- Not for use in Type 1 diabetes or diabetic ketoacidosis.
- Avoid in patients with severe kidney disease (eGFR <30 mL/min) or those on dialysis.
- Medical Conditions: Inform your doctor if you have:
- Kidney or liver problems.
- History of urinary tract or genital infections.
- Heart failure or cardiovascular disease.
- Low blood pressure or dehydration risk.
- Diabetic ketoacidosis history.
- Pregnancy and Breastfeeding:
- May be unsafe during pregnancy, especially in the second and third trimesters, due to potential harm to the fetus. Consult a doctor for risk-benefit assessment.
- Probably unsafe during breastfeeding, as it may pass into breastmilk and harm the baby.
- Alcohol: Avoid alcohol, as it may increase the risk of side effects like dehydration or low blood sugar.
- Driving: Use caution if blood sugar levels are unstable, as low or high blood sugar may impair alertness or cause dizziness.
- Children: Not recommended for children under 10 years due to limited safety data.
-
Drug Interactions:
- Medications to Avoid or Monitor:
- Other diabetes medications (e.g., insulin, sulfonylureas) may increase hypoglycemia risk.
- Diuretics (may worsen dehydration or low blood pressure).
- Antibiotics like gatifloxacin (may affect blood glucose levels).
- General Advice: Inform your doctor about all medications, supplements, or herbal products you are taking to avoid interactions.
-
Storage:
- Store at room temperature (68°F–77°F or 20°C–25°C) in a closed container, away from heat, moisture, and direct light.
- Keep out of reach of children.
- Do not use expired tablets or those no longer needed.
-
Benefits:
- Effectively lowers blood sugar without causing significant hypoglycemia when used alone.
- Reduces the risk of cardiovascular and kidney complications in Type 2 diabetes.
- May promote modest weight loss and improve heart failure outcomes.
- Convenient once-daily dosing.
-
Lifestyle Recommendations:
For optimal results, combine Empagliflozin with:
- A healthy diet low in refined sugars and high in fiber.
- Regular physical activity (e.g., 150 minutes of moderate exercise per week).
- Weight management to reduce diabetes-related complications.
- Staying hydrated to counter increased urination and dehydration risk.